174 related articles for article (PubMed ID: 25789705)
1. Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model.
Chan ES; Herlitz LC; Jabbari A
J Invest Dermatol; 2015 Jul; 135(7):1912-1915. PubMed ID: 25789705
[No Abstract] [Full Text] [Related]
2. Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial.
Okon L; Rosenbach M; Krathen M; Rose M; Propert K; Okawa J; Werth V
J Am Acad Dermatol; 2014 Mar; 70(3):583-4. PubMed ID: 24528907
[No Abstract] [Full Text] [Related]
3. The effect of hydroxychloroquine on lupus erythematosus-like skin lesions in MRL/lpr mice.
Shimomatsu T; Kanazawa N; Mikita N; Nakatani Y; Li HJ; Inaba Y; Ikeda T; Kondo T; Furukawa F
Mod Rheumatol; 2016 Sep; 26(5):744-8. PubMed ID: 26873035
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous lupus mucinosis successfully treated with systemic corticosteroid and systemic tacrolimus combination therapy.
Sugiura K; Tanahashi K; Muro Y; Akiyama M
J Am Acad Dermatol; 2013 Oct; 69(4):e200-2. PubMed ID: 24034403
[No Abstract] [Full Text] [Related]
5. Psoriasis coexisting with subacute cutaneous lupus erythematosus.
Kontochristopoulos GJ; Giannadaki M; Doulaveri G; Christofidou E; Zakopoulou N
J Eur Acad Dermatol Venereol; 2004 May; 18(3):385-6. PubMed ID: 15096170
[No Abstract] [Full Text] [Related]
6. Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease.
King JK; Philips RL; Eriksson AU; Kim PJ; Halder RC; Lee DJ; Singh RR
J Immunol; 2015 Jul; 195(2):464-76. PubMed ID: 26071559
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the peripheral benzodiazepine receptor in the development of cutaneous pathology in Mrl/Lpr mice.
Bribes E; Galiegue S; Bourrie B; Casellas P
Immunol Lett; 2003 Jan; 85(1):13-8. PubMed ID: 12505191
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous lupus erythematosus.
Eastham AB; Vleugels RA
JAMA Dermatol; 2014 Mar; 150(3):344. PubMed ID: 24623331
[No Abstract] [Full Text] [Related]
9. JAK1/2 Inhibitor Ruxolitinib Controls a Case of Chilblain Lupus Erythematosus.
Wenzel J; van Holt N; Maier J; Vonnahme M; Bieber T; Wolf D
J Invest Dermatol; 2016 Jun; 136(6):1281-1283. PubMed ID: 26916391
[No Abstract] [Full Text] [Related]
10. Subacute cutaneous lupus erythematosus presenting in a child.
Ciconte A; Mills AE; Shipley A; Marks R
Australas J Dermatol; 2002 Feb; 43(1):62-4. PubMed ID: 11869212
[TBL] [Abstract][Full Text] [Related]
11. Murine models of cutaneous involvement in lupus erythematosus.
Ghoreishi M; Dutz JP
Autoimmun Rev; 2009 May; 8(6):484-7. PubMed ID: 19239927
[TBL] [Abstract][Full Text] [Related]
12. Lupus miliaris disseminatus faciei: treatment with the 1450-nm diode laser.
Jih MH; Friedman PM; Kimyai-Asadi A; Friedman ES; Hymes SR; Goldberg LH
Arch Dermatol; 2005 Feb; 141(2):143-5. PubMed ID: 15724009
[No Abstract] [Full Text] [Related]
13. Lupus erythematosus masquerading as erythema multiforme: does Rowell syndrome really exist?
Modi GM; Shen A; Mazloom A; Mawad J; Perez A; Sonabend ML; Hsu S
Dermatol Online J; 2009 Feb; 15(2):5. PubMed ID: 19336022
[No Abstract] [Full Text] [Related]
14. Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.
Günther C; Meurer M; Stein A; Viehweg A; Lee-Kirsch MA
Dermatology; 2009; 219(2):162-6. PubMed ID: 19478477
[TBL] [Abstract][Full Text] [Related]
15. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
16. JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosus.
Klaeschen AS; Wolf D; Brossart P; Bieber T; Wenzel J
Exp Dermatol; 2017 Aug; 26(8):728-730. PubMed ID: 27892610
[TBL] [Abstract][Full Text] [Related]
17. A case of nodular cutaneous lupus mucinosis.
Terao H; Moroi Y; Urabe K; Koga T; Furue M
J Dermatol; 2003 Apr; 30(4):341-3. PubMed ID: 12707473
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Japanese-Chinese herbal medicine, kampo, for the treatment of lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice.
Kanauchi H; Imamura S; Takigawa M; Furukawa F
J Dermatol; 1994 Dec; 21(12):935-9. PubMed ID: 7868765
[TBL] [Abstract][Full Text] [Related]
19. Subacute cutaneous lupus erythematosus induced by nivolumab.
Liu RC; Sebaratnam DF; Jackett L; Kao S; Lowe PM
Australas J Dermatol; 2018 May; 59(2):e152-e154. PubMed ID: 28726325
[No Abstract] [Full Text] [Related]
20. Dome-shaped nodules and scaly, verruciform plaques on the legs and feet.
Alcántara-Reifs CM; Salido-Vallejo R; Garnacho-Saucedo GM; GarcIa-Nieto AV
Indian J Dermatol Venereol Leprol; 2019; 85(2):226-228. PubMed ID: 29620042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
